A phase I dose escalation study of sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Reck, M.
Frickhofen, N.
Gatzemeier, U.
Fuhr, H.
Lanzalone, S.
Lechuga, M. J.
Wang, E.
Chao, R.
Felip, E.
机构：
[1] Hosp Grosshansdorf, Grosshansdorf, Germany
[2] Dr Horst Schmidt Klin, HSK, Wiesbaden, Germany
[3] Pfizer Italia Srl, Milan, Italy
[4] Pfizer Global Res & Dev, La Jolla, CA USA
[5] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study
    Reck, Martin
    Frickhofen, Norbert
    Cedres, Susana
    Gatzemeier, Ulrich
    Heigener, David
    Fuhr, Heinz-Georg
    Thall, Aron
    Lanzalone, Silvana
    Stephenson, Patricia
    Ruiz-Garcia, Ana
    Chao, Richard
    Felip, Enriqueta
    [J]. LUNG CANCER, 2010, 70 (02) : 180 - 187
  • [2] Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)
    Reck, M.
    Frickhofen, N.
    Gatzemeier, U.
    Fuhr, H. G.
    Lanzalone, S.
    Wang, E.
    Chao, R.
    Felip, E.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 390 - 390
  • [3] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [4] Vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small cell lung cancer (NSCLC): A Phase I dose-escalation study
    Tredaniel, J.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J.
    Gachard, E.
    Garcia-Vargas, J.
    Roben, E.
    Zalcman, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Burkes, RL
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    Schulz, M
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (05) : 48 - 54
  • [6] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [7] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    [J]. LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [8] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [9] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [10] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
12345